We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

220 hedge funds and large institutions have $2.72B invested in Myriad Genetics in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 76 increasing their positions, 86 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $2.12B → $2.72B (+$598M)

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

8% less funds holding

Funds holding: 239 → 220 (-19)

10.75% less ownership

Funds ownership: 120.73% → 109.98% (-11%)

12% less repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 86

35% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 37

50% less call options, than puts

Call options by funds: $9.46M | Put options by funds: $19M

Holders
220
Holders Change
-19
Holders Change %
-7.95%
% of All Funds
5.48%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.15%
New
24
Increased
76
Reduced
86
Closed
37
Calls
$9.46M
Puts
$19M
Net Calls
-$9.57M
Net Calls Change
-$14.3M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.3M
2
CM
Castleark Management
Illinois
+$12.1M
3
Wells Fargo
Wells Fargo
California
+$11.9M
4
Deutsche Bank
Deutsche Bank
Germany
+$9.75M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$9.64M

Top Sellers

Rank Fund Capital Flow
1
SCM
Sterling Capital Management
North Carolina
-$52.5M
2
First Trust Advisors
First Trust Advisors
Illinois
-$52.2M
3
CCM
Consonance Capital Management
New York
-$36.9M
4
CCM
Camber Capital Management
Massachusetts
-$28.5M
5
Millennium Management
Millennium Management
New York
-$24.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIP
226
Convergence Investment Partners
Florida
– -$1.54M -59,770 Closed
EGM
227
Engineers Gate Manager
New York
– -$1.47M -56,841 Closed
CCMG
228
Clark Capital Management Group
Pennsylvania
– -$1.23M -47,429 Closed
Susquehanna International Group
229
Susquehanna International Group
Pennsylvania
– -$1.25M -43,846 Closed
SCA
230
STALEY CAPITAL ADVISERS
Pennsylvania
– -$850K -32,894 Closed
CEI
231
Clark Estates Inc
New York
– -$646K -25,000 Closed
AIMCA
232
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$641K -24,800 Closed
BCM
233
Bayesian Capital Management
New York
– -$594K -23,000 Closed
LCM
234
Laurion Capital Management
New York
– -$532K -20,600 Closed
OPPM
235
Opus Point Partners Management
New York
– -$527K -20,414 Closed
BFM
236
Boothbay Fund Management
New York
– -$409K -15,843 Closed
Jane Street
237
Jane Street
New York
– -$374K -14,458 Closed
SGAM
238
Smith Group Asset Management
Texas
– -$369K -14,290 Closed
HT
239
HAP Trading
New York
– -$360K -13,942 Closed
PCM
240
Prelude Capital Management
New York
– -$312K -12,092 Closed
JG
241
Jefferies Group
New York
– -$255K -9,875 Closed
JMPWA
242
JP Morgan Private Wealth Advisors
California
– -$248K -9,597 Closed
TA
243
Tiedemann Advisors
New York
– -$211K -8,175 Closed
NIT
244
NumerixS Investment Technologies
British Columbia, Canada
– -$165K -6,400 Closed
FT
245
Fiduciary Trust
Massachusetts
– -$113K -4,365 Closed
DADC
246
D.A. Davidson & Co
Montana
– -$95K -3,699 Closed
BTIS
247
BB&T Investment Services
North Carolina
– -$90K -3,422 Closed
AP
248
Advisors Preferred
Maryland
– -$47K -1,829 Closed
Pacer Advisors
249
Pacer Advisors
Pennsylvania
– -$36K -1,390 Closed
GI
250
Gradient Investments
Minnesota
– -$11K -420 Closed
7 8 9
10
11

MYGN Hedge Fund Activity: Q3 2017 in Review

220 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q3 2017, worth a combined $2.72B — up 28% from $2.12B a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of MYGN and 24 opened new positions — a net loss of 13 holders — while 86 trimmed existing stakes and 76 added.

The largest buyer was BlackRock, adding an estimated $13.3M. The largest seller was Sterling Capital Management, cutting an estimated $52.5M.

  • 220 institutional investors held Myriad Genetics (MYGN) as of Q3 2017, down from 239 in Q2 2017.
  • Funds reported $2.72B of Myriad Genetics stock for Q3 2017, up 28% quarter-over-quarter.
  • 24 funds opened new Myriad Genetics positions in Q3 2017 and 37 closed out, a net change of -13 holders.
  • The largest Myriad Genetics buyer in Q3 2017 was BlackRock, an estimated $13.3M added.
  • The largest Myriad Genetics seller in Q3 2017 was Sterling Capital Management, an estimated $52.5M sold.

Based on aggregated 13F filings for Q3 2017.